Navigation Links
2009 Lasker Awards recognize promise of stem cells -- global market could top $700 million
Date:9/14/2009

New Rochelle, NY, September 14, 2009The recipients of The 2009 Lasker Awards, announced today, represent the dramatic advances achieved in biotechnology research that have led to a revolutionary cancer treatment and the tremendous promise of stem cell therapy for regenerative medicine. Such advances portend a potential $700 million global market for new therapies within less than five years, according to Genetic Engineering & Biotechnology News (GEN, www.genengnews.com).

The Albert Lasker Basic Medical Research Award for 2009 recognizes discoveries in the process that instructs specialized adult cells to form stem cells, and will be presented to Sir John Gurdon, DPhil, DSc, FRS, Emeritus Professor and Group Leader, Gurdon Institute of Cancer & Developmental Biology, University of Cambridge, and Shinya Yamanaka, MD, PhD, Institute for Integrated Cell-Material Sciences, Kyoto University.

The 2009 Lasker-DeBakey Clinical Medical Research Award honors outstanding therapeutic research on chronic myeloid leukemia, and will be given to Brian J. Druker, MD, Professor of Medicine and Director of the Leukemia Center, Oregon Health Sciences University, Nicholas B. Lydon, PhD, formerly of Novartis, and Charles L. Sawyers, MD, Head of the Laboratory in Human Oncology and Pathogenesis, Memorial Sloan-Kettering Cancer Center.

Providing insight and expert commentary on the awards in an article appearing today on the GEN website (www.genengnews.com) are prominent scientists Professor Sir Ian Wilmut, editor of the journal Cloning and Stem Cells (www.liebertpub.com/clo), and Graham Parker, PhD, editor of Stem Cells and Development (www.liebertpub.com/scd). Also providing authoritative perspectives are Maria Freire, PhD, president of the Lasker Foundation, Peter C. Johnson, MD, president and CEO of Scintellix and executive vice president and chief medical officer at Entegrion, and Linda Powers, co-founder and managing director of Toucan Capital, which manages a portfolio that includes 16 stem cell or regenerative medicine companies.

"The 2009 Lasker Awards for basic and clinical research underscore the enormous impact that scientific research and translational medicine will have on human health," said John Sterling, Editor in Chief of GEN. "In the areas of embryonic and adult stem cells, this international recognition of the implications for nuclear reprogramming techniques and the ability to produce stem cells capable of regenerating tissues and organs damaged by disease, trauma, or age, will ignite new research ventures and collaborative partnerships and spark investment across the life sciences sector."

"Both embryonic and adult stem cells offer enormous promise for new treatments and cures," said Mary Ann Liebert, president and CEO of Mary Ann Liebert, Inc. "It is urgent that any health care reform policy ensures coverage for stem cell therapies, gene therapies, tissue engineering, and other regenerative therapeutics and technologies," she said.


'/>"/>

Contact: John Sterling
jsterling@genengnews.com
914-740-2196
Mary Ann Liebert, Inc./Genetic Engineering News
Source:Eurekalert

Related biology news :

1. Anthony S. Fauci awarded Lasker Award for Public Service
2. MGH researcher Gary Ruvkun named a co-recipient of the Lasker Award
3. Gladstones Shinya Yamanaka wins Lasker Award
4. The American Society of Plant Biologists announces 2007 awards
5. Singapore National Science and Technology Awards
6. Homeland Security awards 2 grants to Rutgers for nuclear threat detection
7. NIH awards nearly $23M to University of Chicago for translational research
8. NIH awards researcher $1.5 million new innovator grant for fruit-fly studies of prion proteins
9. PETA awards $120,000 to Duluth Foundation for advancing non-animal tests
10. NIH awards UC $9 million grant to improve patient point-of-care technologies
11. NIST announces 56 new awards for innovative technology research and development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... , March 27, 2017  Catholic Health Services ... Management Systems Society (HIMSS) Analytics for achieving Stage ... Model sm . In addition, CHS previously earned ... hospitals using an electronic medical record (EMR). ... high level of EMR usage in an outpatient ...
(Date:3/23/2017)... 2017 Research and Markets has announced the ... Trends - Industry Forecast to 2025" report to their offering. ... The Global ... of around 8.8% over the next decade to reach approximately $14.21 ... market estimates and forecasts for all the given segments on global ...
(Date:3/20/2017)... March 20, 2017 At this year,s CeBIT Chancellor ... biometrics manufacturer DERMALOG. The Chancellor came to the DERMALOG stand together with ... this year,s CeBIT partner country. At the largest German biometrics company the ... fingerprint, face and iris recognition as well as DERMALOG´s multi-biometrics system.   ... ...
Breaking Biology News(10 mins):
(Date:4/20/2017)... , ... April 20, 2017 , ... ... of a unique intellectual property (IP) sharing and commercialization model. , The Center ... inventions. A main component of this effort is bringing the IP to the ...
(Date:4/20/2017)... and PETACH TIKVAH, Israel , ... a leading developer of adult stem cell technologies for neurodegenerative ... Officer, will present at the Alliance for Regenerative Medicine,s (ARM) ... on Thursday, April 27, 2017 at 09:40 EDT in ... Ralph Kern , MD, MHSc, Chief Medical Officer & Chief ...
(Date:4/19/2017)... (PRWEB) , ... April 18, 2017 , ... ... 1970s and has been a key device for generating monodisperse droplets of known ... droplet processes and for generating monodisperse solid particles by drying monodisperse droplets. ...
(Date:4/19/2017)... ... April 18, 2017 , ... Alisa Wright, founder and CEO of ... Purdue College of Pharmacy in Lafayette, Indiana. , The Distinguished Alumni Award was ... their careers and other scientific endeavors. , Wright began her career in the ...
Breaking Biology Technology: